A UK biomaterials SME has developed novel peptide hydrogels that can be modified to mimic different tissues and provide a cost-effective, animal free 3D matrix to support a range of cell culture applications.
Volíem informar de la següent petició en el Enterprise Europe Network:
The UK-based SME seeking partners is a 3D biomaterials company with a core expertise in the development and manufacture of synthetic 3D peptide hydrogels. These novel patented 3D peptide hydrogels can be chemically and mechanically modified to mimic different tissues and provide a cost effective, animal free 3D matrix to support a range of exciting high growth applications including;
- 3D Cell Culture
- 3D Bioprinting
- Tissue Engineering & Regeneration
- In vitro Models for Drug and Cosmetic Screening
- Drug Delivery
The hydrogel technology has been shown to promote cell adhesion, growth and proliferation in a range of applications, with current programmes indicating success with a variety of cell types including stem cells, neuronal cells, keratinocytes, and hepatocytes. The materials are currently being used in the study of diseases such as osteoarthritis and cancer, as well as the development of skin models and spinal cord repair treatments.
The key advantages of the SME's hydrogel technology are that the materials are:
- Fully synthetic - They contain no animal-derived material, but are composed of biologically relevant peptides which display consistent physical properties when manufactured.
- Totally Tuneable - Stiffness and chemistry environment can be tuned to match cell environment.
- Flexible Handling - Provided as a powder. Culture media induces gelation, no temperature or pH dependence. They are injectable.
The SME possesses significant expertise in the manufacture and formulation development of peptide hydrogels and has the capabilities to design and develop bespoke formulations to meet clients' specific requirements. In order to validate its hydrogel technology as an effective synthetic 3D matrix for a variety of cell culture applications, the company is seeking partners in the areas of cell culture, in vitro assays, and bioprinting who wish to develop more physiologically relevant in vitro models, who require an alternative 3D matrix/ scaffold to that which they are currently using or are developing a new application in which a hydrogel scaffold would be beneficial.
Referència: TRUK20180319002
Link: https://een.ec.europa.eu/tools/services/PRO/Profile/Detail/dba4db08-69aa-43f7-b2e2-10e1c12148f6?shid=32db25cb-726f-43b0-8b5f-7742d0935799
Si us interessa alguna tecnologia podeu iniciar les converses, però recordeu guardar la confidencialitat i si heu d'entrar en detall realitzeu un conveni confidencialitat, a la Unitat de Valorització disposem de models en diferents idiomes. En cas que les converses fossin positives hauríeu de formalitzar-ho amb un conveni de recerca per tal de regular la recerca.
Finalment si el que voleu és fer ofertes tecnològiques de la vostra recerca, us agrairem que us poseu en contacte amb la Unitat de Valorització. valoritzacio@udg.edu
Per a més informació podeu contactar amb nosaltres a valoritzacio@udg.edu